Liquid biopsy seen as one disruptive technology

Forces potentially disruptive to mainstream clinical laboratory practice lie ahead, Gregory J. Tsongalis, PhD, director of molecular pathology and clinical genomics at Dartmouth’s Geisel School of Medicine, said in a War College presentation in May.

The lede to another piece in this month’s “Put It on the Board” section. Read the whole shebang.